In Vitro Susceptibility of Canine Influenza A (H3N8) Virus to Nitazoxanide and Tizoxanide

Infection of dogs with canine Influenza Virus (CIV) is considered widespread throughout the United States following the first isolation of CIV in 2004. While vaccination against influenza A Infection is a common and important practice for disease control, Antiviral therapy can serve as a valuable adjunct in controlling the impact of the disease. In this study, we examined the Antiviral activity of nitazoxanide (NTZ) and tizoxanide (TIZ) against three CIV isolates in vitro. NTZ and TIZ inhibited virus replication of all CIVs with 50% and 90% inhibitory concentrations ranging from 0.17 to 0.21 μM and from 0.60 to 0.76 μM, respectively. These results suggest that NTZ and TIZ are effective against CIV and may be useful for treatment of canine influenza in dogs but further investigation of the in vivo efficacy against CIV as well as the drug's potential for toxicity in dogs is needed.